Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Similar articles for PubMed (Select 23530095)

1.

Elevated risk of prostate cancer among men with Lynch syndrome.

Raymond VM, Mukherjee B, Wang F, Huang SC, Stoffel EM, Kastrinos F, Syngal S, Cooney KA, Gruber SB.

J Clin Oncol. 2013 May 10;31(14):1713-8. doi: 10.1200/JCO.2012.44.1238. Epub 2013 Mar 25.

2.

Risks of Lynch syndrome cancers for MSH6 mutation carriers.

Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH; Dutch Lynch Syndrome Study Group, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, Young J, Walsh MD, Jass J, Macrae F, Antill Y, Winship IM, Giles GG, Goldblatt J, Parry S, Suthers G, Leggett B, Butz M, Aronson M, Poynter JN, Baron JA, Le Marchand L, Haile R, Gallinger S, Hopper JL, Potter J, de la Chapelle A, Vasen HF, Dunlop MG, Thibodeau SN, Jenkins MA.

J Natl Cancer Inst. 2010 Feb 3;102(3):193-201. doi: 10.1093/jnci/djp473. Epub 2009 Dec 22.

3.

Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB.

Gastroenterology. 2009 Nov;137(5):1621-7. doi: 10.1053/j.gastro.2009.07.039. Epub 2009 Jul 18.

4.

High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.

Mukherjee B, Rennert G, Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB.

Gastroenterology. 2011 Jun;140(7):1919-26. doi: 10.1053/j.gastro.2011.02.071. Epub 2011 Mar 16.

PMID:
21419771
5.

Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.

Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA.

J Natl Cancer Inst. 2012 Sep 19;104(18):1363-72. Epub 2012 Aug 28.

6.

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A.

Gastroenterology. 2008 Aug;135(2):419-28. doi: 10.1053/j.gastro.2008.04.026. Epub 2008 May 2.

7.

Germ-line mutations in mismatch repair genes associated with prostate cancer.

Grindedal EM, Møller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landrø SM, Clark N, Kvåle R, Shanley S, Maehle L.

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2460-7. doi: 10.1158/1055-9965.EPI-09-0058. Epub 2009 Sep 1.

8.

Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.

Pande M, Wei C, Chen J, Amos CI, Lynch PM, Lu KH, Lucio LA, Boyd-Rogers SG, Bannon SA, Mork ME, Frazier ML.

Fam Cancer. 2012 Sep;11(3):441-7. doi: 10.1007/s10689-012-9534-6.

10.

Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis.

Ryan S, Jenkins MA, Win AK.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):437-49. doi: 10.1158/1055-9965.EPI-13-1165. Epub 2014 Jan 14. Review.

11.

Is prostate cancer a Lynch syndrome cancer?

Win AK.

Asian J Androl. 2013 Sep;15(5):588-9. doi: 10.1038/aja.2013.87. Epub 2013 Jul 1. No abstract available.

12.

Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.

Matikaine MP, Pukkala E, Schleutker J, Tammela TL, Koivisto P, Sankila R, Kallioniemi OP.

Cancer Causes Control. 2001 Apr;12(3):223-30.

PMID:
11405327
13.

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.

Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, Newcomb PA, Le Marchand L, Haile RW, Lindor NM, Gallinger S, Hopper JL, Jenkins MA.

Gut. 2011 Jul;60(7):950-7. doi: 10.1136/gut.2010.228056. Epub 2010 Dec 30.

14.

The spectrum of urological malignancy in Lynch syndrome.

Barrow PJ, Ingham S, O'Hara C, Green K, McIntyre I, Lalloo F, Hill J, Evans DG.

Fam Cancer. 2013 Mar;12(1):57-63. doi: 10.1007/s10689-012-9573-z.

PMID:
23054215
15.

Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.

da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F.

Fam Cancer. 2010 Dec;9(4):563-70. doi: 10.1007/s10689-010-9373-2.

PMID:
20697958
16.

Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study.

Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):489-98.

PMID:
16616355
17.

Risks of less common cancers in proven mutation carriers with lynch syndrome.

Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO, Schmiegel W, Buettner R, Moeslein G, Letteboer TG, Gómez García E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Wagner A, Kluijt I, Propping P, Vasen HF.

J Clin Oncol. 2012 Dec 10;30(35):4409-15. doi: 10.1200/JCO.2012.43.2278. Epub 2012 Oct 22.

18.

Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model.

Choi YH, Briollais L, Green J, Parfrey P, Kopciuk K.

Stat Med. 2014 Feb 20;33(4):618-38. doi: 10.1002/sim.5938. Epub 2013 Aug 15.

PMID:
23946183
19.

Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.

Tryggvadottir L, Sigvaldason H, Olafsdottir GH, Jonasson JG, Jonsson T, Tulinius H, Eyfjörd JE.

J Natl Cancer Inst. 2006 Jan 18;98(2):116-22.

20.

Performance of Lynch syndrome predictive models in a multi-center US referral population.

Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J.

Am J Gastroenterol. 2011 Oct;106(10):1822-7; quiz 1828. doi: 10.1038/ajg.2011.200. Epub 2011 Jul 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk